Trauma & PTSD · Texas behavioral health news
Texas is the latest state to embrace psychedelic therapy research for mental health treatment - The American Homefront Project
PTSD & Trauma (Google News) · July 14, 2025
In plain language
Texas is investing up to $50 million to study ibogaine, a psychedelic compound that may help veterans struggling with PTSD, depression, and addiction. This new state law supports research into how these substances might stimulate new brain connections to help people break destructive thought patterns. While some veterans report significant relief from these treatments abroad, these substances remain illegal in the U.S. outside of approved clinical trials. Researchers emphasize that these therapies require careful medical supervision and therapy to manage potential heart risks and difficult psychological experiences.
AI-generated summary of the source article. Not medical advice.
Key takeaways
- Texas authorized $50 million for research into ibogaine as a treatment for mental health and addiction.
- Psychedelics may help the brain form new neural connections to process trauma and end substance use.
- Clinical trials often combine the use of psychedelic compounds with supervised therapy sessions to ensure safety.
- Health risks including cardiac issues and distressing psychological experiences require participants to undergo medical screening.
- Federal agencies like the VA and FDA are increasingly exploring psychedelics for serious mental health conditions.
Texas is the latest state to embrace psychedelic therapy research for mental health treatment The American Homefront Project
Need to talk to someone in Texas? Browse Texas-licensed telehealth therapists. In crisis, call or text 988.